Literature DB >> 22791411

The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex.

Jianhui Xie1.   

Abstract

Natural killer gene complex (NKC) encodes a group of proteins with a single C-type lectin-like domain, (CTLD) which can be subdivided several subfamilies according to their structures and expression patterns. The receptors containing the conserved calcium binding sites in the CTLD fold belong to group II of C-type lectin superfamily and are expressed on myeloid cells and non- myeloid cells. The receptors lacking conserved calcium binding sites in the CTLD fold have evolved to bind ligands other than carbohydrates independently on calcium and thereby are named as C-type lectin-like receptors. The C-type lectin-like receptors are previously thought to be exclusively expressed on natural killer (NK) cells and enable NK cells to discriminate self, missing self or altered self. However, some C-type lectin-like receptors are identified in myeloid cells and are intensely investigated, recently. These myeloid C-type lectin-like receptors, especially Dectin-1 cluster, have a wide variety of ligands, including those of exogenous origin, and play important roles in the physiological functions and pathological processes including immune homeostasis, immune defenses, and immune surveillance. In this review, we summarize each member of the Dectin-1 cluster, including their structural profiles, expression patterns, signaling properties as well as known physiological functions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22791411     DOI: 10.1007/s10719-012-9419-9

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  129 in total

Review 1.  Immune functions encoded by the natural killer gene complex.

Authors:  Wayne M Yokoyama; Beatrice F M Plougastel
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

2.  LOX-1 as a natural IFN-alpha-mediated signal for apoptotic cell uptake and antigen presentation in dendritic cells.

Authors:  Stefania Parlato; Giulia Romagnoli; Francesca Spadaro; Irene Canini; Paolo Sirabella; Paola Borghi; Carlo Ramoni; Ilaria Filesi; Silvia Biocca; Lucia Gabriele; Filippo Belardelli
Journal:  Blood       Date:  2009-12-15       Impact factor: 22.113

3.  Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning.

Authors:  K Ariizumi; G L Shen; S Shikano; S Xu; R Ritter; T Kumamoto; D Edelbaum; A Morita; P R Bergstresser; A Takashima
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

4.  Chlamydia pneumoniae binds to the lectin-like oxidized LDL receptor for infection of endothelial cells.

Authors:  Lee Ann Campbell; Mirja Puolakkainen; Amy Lee; Michael E Rosenfeld; H Jacques Garrigues; Cho-Chou Kuo
Journal:  Microbes Infect       Date:  2011-08-30       Impact factor: 2.700

5.  The C-type lectin-like receptor CLEC-1, expressed by myeloid cells and endothelial cells, is up-regulated by immunoregulatory mediators and moderates T cell activation.

Authors:  Pamela Thebault; Natacha Lhermite; Gaëlle Tilly; Laëtitia Le Texier; Thibaut Quillard; Michele Heslan; Ignacio Anegon; Jean-Paul Soulillou; Sophie Brouard; Beatrice Charreau; Maria-Cristina Cuturi; Elise Chiffoleau
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

6.  The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses.

Authors:  Mireille H Lahoud; Anna I Proietto; Fatma Ahmet; Susie Kitsoulis; Liv Eidsmo; Li Wu; Priyanka Sathe; Suzanne Pietersz; Hsuen-Wen Chang; Ian D Walker; Eugene Maraskovsky; Hal Braley; Andrew M Lew; Mark D Wright; William R Heath; Ken Shortman; Irina Caminschi
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

7.  Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide.

Authors:  Janet A Willment; Hsi-Hsien Lin; Delyth M Reid; Philip R Taylor; David L Williams; Simon Y C Wong; Siamon Gordon; Gordon D Brown
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

8.  Differential use of CARD9 by dectin-1 in macrophages and dendritic cells.

Authors:  Helen S Goodridge; Takahiro Shimada; Andrea J Wolf; Yen-Michael S Hsu; Courtney A Becker; Xin Lin; David M Underhill
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

9.  Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein.

Authors:  H Moriwaki; N Kume; T Sawamura; T Aoyama; H Hoshikawa; H Ochi; E Nishi; T Masaki; T Kita
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-10       Impact factor: 8.311

10.  Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand.

Authors:  Elwira Pyz; Cristal Huysamen; Andrew S J Marshall; Siamon Gordon; Philip R Taylor; Gordon D Brown
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

View more
  4 in total

Review 1.  Possible mechanisms of action of mushroom-derived glucans on inflammatory bowel disease and associated cancer.

Authors:  Betty Schwartz; Yitzhak Hadar
Journal:  Ann Transl Med       Date:  2014-02

Review 2.  Redefining Memory: Building the Case for Adaptive NK Cells.

Authors:  Silke Paust; Catherine A Blish; R Keith Reeves
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

3.  Identification and characterization of Cryptosporidium parvum Clec, a novel C-type lectin domain-containing mucin-like glycoprotein.

Authors:  Seema Bhalchandra; Jacob Ludington; Isabelle Coppens; Honorine D Ward
Journal:  Infect Immun       Date:  2013-07-01       Impact factor: 3.441

4.  Curdlan Limits Mycobacterium tuberculosis Survival Through STAT-1 Regulated Nitric Oxide Production.

Authors:  Shikha Negi; Susanta Pahari; Deepjyoti Kumar Das; Nargis Khan; Javed N Agrewala
Journal:  Front Microbiol       Date:  2019-05-28       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.